Abstract:The aggregation of amyloid-β peptides (Aβ) is considered as one of the mainly possible causes of the Alzheimer's diseases (AD). How to suppress the formation of toxic Aβ aggregates has been intensively concerned over the past several decades. Increasing evidence shows that whether carbon nano-materials could suppress or promote the aggregation depend on their physicochemical properties. However, as amyloid fibrillization is a complex process, their interaction dynamics remains elusive. In this presentation, we have investigated the interaction between Aβ(16-22) peptides/full-length Aβ peptides and three kinds of carbon nanomaterials (carbon nanotube, fullerene, and graphene) by utilizing atomic force microscopy (AFM), electrostatic force microscopy (EFM), Thioflavin T (ThT) fluorescence, combined with molecular dynamic (MD) simulations. Our experimental results demonstrate that all of the three carbon nano-materials could suppress the process of Aβ fibrillation. EFM and ThT fluorescence results further confirmed that the Aβ peptides are strongly absorbed on the surface of carbon nano-materials by forming non-fibrillar aggregates. At the molecular scale, it is found that carbon nano-materials dramatically inhibit the formation of ordered β-sheet-rich structures as the strong hydrophobic and aromatic stacking interactions between carbon nano-materials and Aβ peptides. In comparison, the fullerenes exhibit the most excellent inhibitory ability by the strong aromatic stacking of the fullerene hexagonal rings with the Phe rings, as well as the outstanding biocompatibility. Furthermore, we found that the bare carbon nanotube could dissociate the preformed fibrils to some extent. Our results provide novel clues for studying interaction in amyloid/carbon-material system and seeking amyloidosis inhibitors with carbon nanomaterials, which may have important potentials in the development of drug candidates against Alzheimer's disease.

Nanostructural Differentiation and Toxicity of Amyloid-β25-35 Aggregates Ensue from Distinct Secondary Conformation

Molecular Simulations of Amyloid Structures, Toxicity, and Inhibition

Identification of a Novel Parallel Β‐strand Conformation Within Molecular Monolayer of Amyloid Peptide

Location and conformation of amyloid β(25-35) peptide and its sequence-shuffled peptides within membranes: implications for aggregation and toxicity in PC12 cells.

The Relationship Between Amyloid Structure and Cytotoxicity.

Impact of Alternating Amino Acid Sequences on Beta-Amyloid-induced Neurotoxicity and Neuroinflammation in Alzheimer's Disease.

Aggregation mechanisms and molecular structures of amyloid‐β in Alzheimer's disease

N-terminal Domain of Amyloid-β Impacts Fibrillation and Neurotoxicity

Polymorphism in Alzheimer Aβ Amyloid Organization: Insight into Aβ Aggregation

Comparison Of Neurotoxicity Of Different Aggregated Forms Of A Beta 40, A Beta 42 And A Beta 43 In Cell Cultures

A Relationship between the Structures and Neurotoxic Effects of Aβ Oligomers Stabilized by Different Metal Ions

Comparison of neurotoxicity of different aggregated forms of A<i>β</i>40, A<i>β</i>42 and A<i>β</i>43 in cell cultures

Hierarchical chemical determination of amyloid polymorphs in neurodegenerative disease

Amyloid-β Peptide Aggregation and the Influence of Carbon Nanoparticles

Morphology and Structural Dynamics of Amyloid Beta 42 Assembly in Vitro

Study of biologic characters of Aβ42 and Aβ42 oligomer

Aβ1-16 Can Aggregate and Induce the Production of Reactive Oxygen Species, Nitric Oxide, and Inflammatory Cytokines.

Site-specific chirality-conferred structural compaction differentially mediates the cytotoxicity of Aβ42

Truncated and Modified Aβ Species in Alzheimer's Disease

Macromolecular and small-molecule modulation of intracellular Aβ42 aggregation and associated toxicity.

Studies of the Interaction Between Aβ Peptides and Carbon Nano-Materials